MannKind Corp
MNKD
#4969
Rank
NZ$2.95 B
Marketcap
NZ$9.64
Share price
0.78%
Change (1 day)
-10.62%
Change (1 year)

MannKind Corp (MNKD) - Net assets

Net assets on the balance sheet as of September 2025 : -NZ$73.6 Million

According to MannKind Corp's latest financial reports the company has -NZ$73.6 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

MannKind Corp - Net assets on balance sheet (from 2004 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-NZ$0.14 Billion-64.1%
2023-12-31$-NZ$0.39 Billion-1.36%
2022-12-31$-NZ$0.4 Billion28.75%
2021-12-31$-NZ$0.31 Billion22.57%
2020-12-31$-NZ$0.26 Billion-11.61%
2019-12-31$-NZ$0.29 Billion8.38%
2018-12-31$-NZ$0.27 Billion-13.67%
2017-12-31$-NZ$0.31 Billion14.08%
2016-12-31$-NZ$0.27 Billion-48.22%
2015-12-31$-NZ$0.52 Billion443.66%
2014-12-31$-NZ$94.16 Million151.92%
2013-12-31$-NZ$37.38 Million-72.22%
2012-12-31$-NZ$0.14 Billion-66.52%
2011-12-31$-NZ$0.41 Billion67.11%
2010-12-31$-NZ$0.25 Billion194.95%
2009-12-31$-NZ$81.54 Million-154.55%
2008-12-31$NZ$0.14 B-68.56%
2007-12-31$NZ$0.47 B-12.68%
2006-12-31$NZ$0.54 B79.76%
2005-12-31$NZ$0.30 B43.7%
2004-12-31$NZ$0.21 B22.77%
2003-12-31$NZ$0.17 B-1.04%
2002-12-31$NZ$0.17 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
NZ$153.79 B-209,060.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$44.13 B-60,064.09%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
NZ$39.40 B-53,634.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$85.75 B-116,608.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$0.83 B-1,231.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$0.14 B-290.98%๐Ÿ‡บ๐Ÿ‡ธ USA